Nisa Investment Advisors, LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Nisa Investment Advisors, LLC

$16.7 Billion
Q3 2024

A detailed history of Nisa Investment Advisors, LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 1,840 shares of ARWR stock, worth $34,886. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,840

Previous 2,396 23.21%

Holding current value

$34,886

Previous $62,000 43.55%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$19.36 - $29.54 $10,764 - $16,424	-556 Reduced 23.21%	1,840 $35,000
Q2 2024 Jul 19, 2024	BUY	$21.87 - $28.24 $87 - $112	4 Added 0.17%	2,396 $62,000
Q1 2024 May 01, 2024	BUY	$27.21 - $39.48 $2,775 - $4,026	102 Added 4.45%	2,392 $68,000
Q4 2023 Jan 25, 2024	SELL	$21.2 - $31.03 $63,176 - $92,469	-2,980 Reduced 56.55%	2,290 $70,000
Q3 2023 Nov 02, 2023	BUY	$26.2 - $36.08 $78,076 - $107,518	2,980 Added 130.13%	5,270 $141,000
Q2 2023 Aug 11, 2023	BUY	$25.16 - $41.38 $7,170 - $11,793	285 Added 14.21%	2,290 $81,000
Q1 2023 May 02, 2023	SELL	$23.68 - $38.51 $134,076 - $218,043	-5,662 Reduced 73.85%	2,005 $51,000
Q4 2022 Feb 02, 2023	BUY	$28.0 - $40.56 $3,948 - $5,718	141 Added 1.87%	7,667 $311,000
Q3 2022 Nov 07, 2022	BUY	$29.63 - $48.31 $5,985 - $9,758	202 Added 2.76%	7,526 $253,000
Q2 2022 Aug 03, 2022	BUY	$27.79 - $50.61 $77,812 - $141,708	2,800 Added 61.89%	7,324 $258,000
Q1 2022 Apr 29, 2022	SELL	$39.62 - $69.97 $87,560 - $154,633	-2,210 Reduced 32.82%	4,524 $208,000
Q4 2021 Feb 03, 2022	SELL	$58.09 - $82.51 $184,145 - $261,556	-3,170 Reduced 32.01%	6,734 $355,000
Q3 2021 Oct 18, 2021	BUY	$58.38 - $84.96 $72,741 - $105,860	1,246 Added 14.39%	9,904 $618,000
Q2 2021 Aug 06, 2021	BUY	$62.15 - $90.32 $59,042 - $85,804	950 Added 12.32%	8,658 $717,000
Q1 2021 Apr 26, 2021	BUY	$61.35 - $90.47 $9,202 - $13,570	150 Added 1.98%	7,708 $511,000
Q4 2020 Jan 25, 2021	BUY	$43.82 - $85.37 $93,029 - $181,240	2,123 Added 39.06%	7,558 $580,000
Q3 2020 Oct 20, 2020	BUY	$33.21 - $51.27 $74,722 - $115,357	2,250 Added 70.64%	5,435 $234,000
Q2 2020 Jul 27, 2020	SELL	$26.12 - $43.27 $146,925 - $243,393	-5,625 Reduced 63.85%	3,185 $138,000
Q1 2020 Apr 17, 2020	SELL	$20.56 - $63.12 $54,072 - $166,005	-2,630 Reduced 22.99%	8,810 $253,000
Q4 2019 Jan 17, 2020	BUY	$28.14 - $73.01 $293,218 - $760,764	10,420 Added 1021.57%	11,440 $726,000
Q3 2019 Oct 17, 2019	BUY	$26.26 - $34.86 $13,130 - $17,430	500 Added 96.15%	1,020 $29,000
Q3 2018 Oct 16, 2018	BUY	$14.0 - $20.3 $7,280 - $10,556	520 New	520 $10,000

Others Institutions Holding ARWR

# of Institutions

294

Shares Held

90.8M

Call Options Held

155K

Put Options Held

426K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.01B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.

Account

Nisa Investment Advisors, LLC Arrowhead Pharmaceuticals, Inc. Transaction History